(1) Adaptive immunity activation: neoplastic cells release threat-associated molecular pattern molecules, pathogen-associated molecular pattern molecules, and a multiplicity of tumor-associated antigens (TAAs) after lysis to recruit immune cells, which infiltrate the tumor and activate CD4+, CD8+ T cells to induce antigen-specific T cell killing [38, 39]. The gene discussed is CD4; the disease is neoplasm.